Clinical Trial Update: A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma [NA]

View source ↗

Summary

A post-market clinical follow-up study was completed to evaluate the safety and performance of Decoria Voluma for midface volume deficit.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Midface Volume Deficit

Drugs mentioned

• Decoria Voluma (hyaluronic acid dermal filler)

Snippet

Sponsor: Bohus Biotech AB | Conditions: Midface Volume Deficit | NA | Status: COMPLETED